BIIB
CEO, Board Member
2022-01-01–present
Board Member
Biogen Inc. (BIIB)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Christopher Viehbacher is recorded as CEO and Board Member at Biogen Inc. (BIIB). The proxy statement of Biogen Inc. reports total compensation of $23,646,004 for Christopher Viehbacher in fiscal 2025, including a base salary of $1,727,885. Disclosed compensation is on record for 4 fiscal years. Christopher Viehbacher has spoken on 6 earnings calls across 1 company, most recently for Biogen Inc. on April 29, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2022-01-01–present
Recorded roles and call appearances connecting this person to public companies.
BIIB
CEO, Board Member
2022-01-01–present
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Biogen Inc. (BIIB) | President and Chief Executive Officer | $1,727,885 | $23,646,004 |
| 2024 | Biogen Inc. (BIIB) | President and CEO | $1,600,000 | $24,166,665 |
| 2023 | Biogen Inc. (BIIB) | President and CEO | $1,600,000 | $4,069,913 |
| 2022 | Biogen Inc. (BIIB) | President and CEO | $153,846 | $30,488,593 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.